Wilson's Disease (also known as hepatolenticular degeneration) is an inherited disorder of copper metabolism that affects multiple organs including the liver, brain, and eyes. It is caused by a mutation of the ATP7B gene, which causes a buildup of copper in the body. This buildup of copper can lead to severe health problems such as cirrhosis of the liver, cognitive deficits, and eye disorders like Kayser-Fleischer rings. Symptoms often appear before adulthood, typically between ages 6 and 20. Common symptoms can include fatigue, lack of appetite, abdominal pain, jaundice, forgetfulness, speech difficulty, muscle spasms, difficulty controlling hand movement, and abnormal behavior. In later stages, Wilson's Disease may affect the brain, brain stems, and neurological systems, leading to more serious symptoms such as tremors, difficulty swallowing, seizures, and liver failure. Treatment for Wilson's Disease is aimed at reducing copper levels in the body and protecting organs from damage caused by the buildup of copper. Establishing a lifelong, comprehensive treatment plan is important for people with Wilson's Disease, as is regular monitoring of copper levels.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States